These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19095642)

  • 1. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals.
    Zitomer NC; Mitchell T; Voss KA; Bondy GS; Pruett ST; Garnier-Amblard EC; Liebeskind LS; Park H; Wang E; Sullards MC; Merrill AH; Riley RT
    J Biol Chem; 2009 Feb; 284(8):4786-95. PubMed ID: 19095642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
    Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
    Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.
    Riley RT; Merrill AH
    J Lipid Res; 2019 Jul; 60(7):1183-1189. PubMed ID: 31048407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
    Rentz SS; Showker JL; Meredith FI; Riley RT
    Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
    Gopee NV; Sharma RP
    Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
    He Q; Riley RT; Sharma RP
    Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective and transient activation of protein kinase C alpha by fumonisin B1, a ceramide synthase inhibitor mycotoxin, in cultured porcine renal cells.
    Gopee NV; Sharma RP
    Life Sci; 2004 Feb; 74(12):1541-59. PubMed ID: 14729403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
    Desai K; Sullards MC; Allegood J; Wang E; Schmelz EM; Hartl M; Humpf HU; Liotta DC; Peng Q; Merrill AH
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):188-92. PubMed ID: 12531553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
    He Q; Riley RT; Sharma RP
    Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor.
    Humpf HU; Schmelz EM; Meredith FI; Vesper H; Vales TR; Wang E; Menaldino DS; Liotta DC; Merrill AH
    J Biol Chem; 1998 Jul; 273(30):19060-4. PubMed ID: 9668088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
    Suzuki H; Riley RT; Sharma RP
    Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
    He Q; Kim J; Sharma RP
    Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity.
    Gable K; Gupta SD; Han G; Niranjanakumari S; Harmon JM; Dunn TM
    J Biol Chem; 2010 Jul; 285(30):22846-52. PubMed ID: 20504773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction and analysis of fumonisins and compounds indicative of fumonisin exposure in plant and mammalian tissues and cultured cells.
    Zitomer NC; Riley RT
    Methods Mol Biol; 2011; 739():171-85. PubMed ID: 21567327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells.
    Sharma N; He Q; Sharma RP
    Chem Biol Interact; 2004 Dec; 151(1):33-42. PubMed ID: 15607760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
    Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
    J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
    Kim MS; Lee DY; Wang T; Schroeder JJ
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.